Liquid biopsy for cancer patients: Principles and practice

Pathogenesis

Volumn 2, Issue 1-2, 2015, Pages 1-4

  Cree, Ian A ^a  

^a UNIVERSITY HOSPITALS COVENTRY AND WARWICKSHIRE NHS TRUST   (United Kingdom)

Author keywords

Biomarker; Blood; Circulating tumour cells; DNA; Liquid biopsy; RNA

Indexed keywords

ADVANCED GLYCATION END PRODUCT; CA 125 ANTIGEN; CA 15-3 ANTIGEN; CA 19-9 ANTIGEN; CA 72-4 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN 19 FRAGMENT; DNA; HIGH MOBILITY GROUP B1 PROTEIN; MICRORNA; PROSTATE SPECIFIC ANTIGEN; PROTEIN S 100; RNA; THYMIDINE KINASE; TUMOR PROTEIN;

AUTOMATION; BIOPSY; BREAST CANCER; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RECURRENCE; CELL DEATH; CIRCULATING TUMOR CELL; CLINICAL PRACTICE; CLINICAL TRIAL (TOPIC); EDITORIAL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNITY; IMMUNOTHERAPY; LIQUID BIOPSY; METHYLATION; NUCLEOSOME; POLYMERASE CHAIN REACTION; SYSTEMATIC REVIEW (TOPIC); TRANSTHORACIC BIOPSY;

EID: 84931563886     PISSN: None     EISSN: 22146636     Source Type: Journal    
DOI: 10.1016/j.pathog.2015.05.001     Document Type: Editorial

References (26)

1. Cree I.A. Improved blood tests for cancer screening: general or specific?. BMC Cancer 2011, 11:499. PubMed PMID: 22128772. Pubmed Central PMCID: 3285105.
2. Shaw J.A., Brown J., Coombes R.C., Jacob J., Payne R., Lee B., et al. Circulating tumor cells and plasma DNA analysis in patients with indeterminate early or metastatic breast cancer. Biomarkers Med 2011 Feb, 5(1):87-91. PubMed PMID: 21319970.
3. Guttery D.S., Blighe K., Page K., Marchese S.D., Hills A., Coombes R.C., et al. Hide and seek: tell-tale signs of breast cancer lurking in the blood. Cancer Metastasis Rev 2013 Jun, 32(1-2):289-302. PubMed PMID: 23108389.
4. O'Flaherty J.D., Gray S., Richard D., Fennell D., O'Leary J.J., Blackhall F.H., et al. Circulating tumour cells, their role in metastasis and their clinical utility in lung cancer. Lung Cancer 2012 Apr, 76(1):19-25. PubMed PMID: 22209049.
5. Mead R., Duku M., Bhandari P., Cree I.A. Circulating tumour markers can define patients with normal colons, benign polyps, and cancers. Br J Cancer 2011 Jul 12, 105(2):239-245. PubMed PMID: 21712823. Pubmed Central PMCID: 3142810.
6. Crowley E., Di Nicolantonio F., Loupakis F., Bardelli A. Liquid biopsy: monitoring cancer-genetics in the blood. Nat Rev Clin Oncol 2013 Aug, 10(8):472-484. PubMed PMID: 23836314.
7. Zandberga E., Kozirovskis V., Abols A., Andrejeva D., Purkalne G., Line A. Cell-free microRNAs as diagnostic, prognostic, and predictive biomarkers for lung cancer. Genes, Chromosomes Cancer 2013 Apr, 52(4):356-369. PubMed PMID: 23404859.
8. Heitzer E., Ulz P., Belic J., Gutschi S., Quehenberger F., Fischereder K., et al. Tumor-associated copy number changes in the circulation of patients with prostate cancer identified through whole-genome sequencing. Genome Med 2013 Apr 5, 5(4):30. PubMed PMID: 23561577. Pubmed Central PMCID: 3707016.
9. Martinez-Galan J., Torres-Torres B., Nunez M.I., Lopez-Penalver J., Del Moral R., Ruiz De Almodovar J.M., et al. ESR1 gene promoter region methylation in free circulating DNA and its correlation with estrogen receptor protein expression in tumor tissue in breast cancer patients. BMC Cancer 2014, 14:59. PubMed PMID: 24495356. Pubmed Central PMCID: 3922625.
10. Church T.R., Wandell M., Lofton-Day C., Mongin S.J., Burger M., Payne S.R., et al. Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer. Gut 2014 Feb, 63(2):317-325. PubMed PMID: 23408352. Pubmed Central PMCID: 3913123.
11. Ulivi P., Foschi G., Mengozzi M., Scarpi E., Silvestrini R., Amadori D., et al. Peripheral blood miR-328 expression as a potential biomarker for the early diagnosis of NSCLC. Int J Mol Sci 2013, 14(5):10332-10342. PubMed PMID: 23681013. Pubmed Central PMCID: 3676841.
12. Sanfiorenzo C., Ilie M.I., Belaid A., Barlesi F., Mouroux J., Marquette C.H., et al. Two panels of plasma microRNAs as non-invasive biomarkers for prediction of recurrence in resectable NSCLC. PloS One 2013, 8(1):e54596. PubMed PMID: 23342174. Pubmed Central PMCID: 3546982.
13. Duffy M.J. How to validate a new cancer biomarker: from discovery to clinical application. Tumor Biol 2014, 35:S2.
14. Leon S.A., Shapiro B., Sklaroff D.M., Yaros M.J. Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res 1977 Mar, 37(3):646-650. PubMed PMID: 837366.
15. Sunami E., Vu A.T., Nguyen S.L., Giuliano A.E., Hoon D.S. Quantification of LINE1 in circulating DNA as a molecular biomarker of breast cancer. Ann N Y Acad Sci 2008 Aug, 1137:171-174. PubMed PMID: 18837943.
16. Sunami E., Vu A.T., Nguyen S.L., Hoon D.S. Analysis of methylated circulating DNA in cancer patients' blood. Methods Mol Biol 2009, 507:349-356. PubMed PMID: 18987826.
17. Thierry A.R., Mouliere F., El Messaoudi S., Mollevi C., Lopez-Crapez E., Rolet F., et al. Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA. Nat Med 2014 Mar 23, 20(4). PubMed PMID: 24658074.
18. Hindson C.M., Chevillet J.R., Briggs H.A., Gallichotte E.N., Ruf I.K., Hindson B.J., et al. Absolute quantification by droplet digital PCR versus analog real-time PCR. Nat Methods 2013 Oct, 10(10):1003-1005. PubMed PMID: 23995387.
19. Molina R., Holdenrieder S., Auge J.M., Schalhorn A., Hatz R., Stieber P. Diagnostic relevance of circulating biomarkers in patients with lung cancer. Cancer biomarkers. Sect A Dis Markers 2010, 6(3-4):163-178. PubMed PMID: 20660962.
20. Wittwer C., Boeck S., Heinemann V., Haas M., Stieber P., Nagel D., et al. Circulating nucleosomes and immunogenic cell death markers HMGB1, sRAGE and DNAse in patients with advanced pancreatic cancer undergoing chemotherapy. Int J Cancer J Int du Cancer 2013 Dec 1, 133(11):2619-2630. PubMed PMID: 23729200.
21. Alix-Panabieres C., Pantel K. Circulating tumor cells: liquid biopsy of cancer. Clin Chem 2013 Jan, 59(1):110-118. PubMed PMID: 23014601.
22. Pantel K., Alix-Panabieres C. Real-time liquid biopsy in cancer patients: fact or fiction?. Cancer Res 2013 Nov 1, 73(21):6384-6388. PubMed PMID: 24145355.
23. Gao P., Jiao S.C., Bai L., Wang H., Jing F.F., Yang J.L. Detection of circulating tumour cells in gastric and hepatocellular carcinoma: a systematic review. J Int Med Res 2013 Aug, 41(4):923-933. PubMed PMID: 23908550.
24. Bidard F.C., Peeters D.J., Fehm T., Nole F., Gisbert-Criado R., Mavroudis D., et al. Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data. Lancet Oncol 2014 Mar 10, 15(4). PubMed PMID: 24636208.
25. Riethdorf S., Fritsche H., Muller V., Rau T., Schindlbeck C., Rack B., et al. Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system. Clin Cancer Res 2007 Feb 1, 13(3):920-928. An Official Journal of the American Association for Cancer Research, PubMed PMID: 17289886.
26. Hong B., Zu Y. Detecting circulating tumor cells: current challenges and new trends. Theranostics 2013, 3(6):377-394. PubMed PMID: 23781285. Pubmed Central PMCID: 3677409.